Celularity Inc
Price
FilingsNewest: 8-K, Director or officer changeSep 29 →InsidersNo open-market buys or sales.→HoldersC V Starr & 2.6%Vanguard 2.1%Geode 0.6%→Financing →PeersClosest companies: COYA, INKT, CMPX→
From the filings
Figures
- Revenue
- $19.0Mlast 12 months
- Net income
- −$71.1Mlast 12 months
- Operating cash flow
- −$8.8Mlast 12 months
- Cash and equivalents
- $368,000at the last balance sheet
- Shares outstanding
- 29.2M shareson issue